at our institution , we encountered three patients who had symptoms of toxicity of the central nervous system ( somnolence , confusion , and gait difficulties ) in association with electroencephalographic abnormalities while receiving alpha 2-interferon therapy for multiple myeloma .
C0021734
alpha 2-interferon
C0026764
myeloma